Subscribe To
Beam Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 17, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management plans to participate in fireside chats during the following May investor conferences: Barclays Virtual Gene Editing & Therapy Summit 2023 on Wednesday, May 24, 2023 at 11:05 a.m. […] The post Beam Therapeutics to Participate in Upcoming May Investor Conferences appeared first on ForexTV...
Read More
Posted: May 17 2023, 10:30
Author Name: forextv
Views: 081599